This article describes the co-design, implementation and use of documentation shortcuts for chlamydia management.
Strategies to improve the implementation of muscle health assessment and management in general practice.
A summary of safety data on respiratory syncytial virus prevention products approved in Australia by the Therapeutic Goods Administration.
An overview of prostate cancer patient support programs in Australia to help general practitioners direct patient referrals and optimise clinical care.
These questions are based on the Focus articles in this issue. Please choose the single best answer for each question.
The unregulated implementation of risk algorithms in tools might miss identifying patients at high risk of cardiovascular disease.
A report on the experiences of Australian general practitioners in 2020 and 2021 during the COVID-19 pandemic.
Although rare, Creutzfeldt–Jakob disease is always fatal. General practitioners are often the first to see the patient, so ongoing awareness of the disease is essential.
Contraceptive options for young people seeking contraception.
Optimal contraceptive choices for women in their 40s.
Recommendations for contributing to the safety and quality of long COVID response in the primary care setting.
This issue explores ‘old’ infectious diseases (scabies, syphilis), ‘new’ infectious diseases (CJD, COVID-19), and medical advances such as RSV prevention products and point-of-care testing.
Syphilis is increasingly prevalent across Australia and should always be included as part of a routine sexual health screen.
The usefulness of modern point-of-care tests for group A streptococci (GAS) is determined by the presence of carriers of GAS.